Numerous provisions of the No Surprises Act, legislation that prohibits surprise medical bills and requires broader price transparency requirements in certain contexts, become effective January 1, 2022. This rapidly approaching effective date raises a host of questions and challenges for hospitals and health systems impacted by the Act and the interim final rules implementing it.

To help hospitals and health systems navigate these new and complex requirements in such a short time frame, this virtual roundtable featured a discussion led by McDermott Will & Emery, McDermott+Consulting and BDO USA LLP.

Featured Speakers:

Ellen Dooley, Director. Healthcare Advisory, BDO USA LLP

Janet Bliss, Partner, Healthcare Advisory, BDO USA LLP